Evidence map›Paper›PMID 12883011›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2003

Repression of c-Myc and inhibition of G1 exit in cells conditionally overexpressing p300 that is not dependent on its histone acetyltransferase activity.

Sudhakar Baluchamy, Hasan N Rajabi, Rama Thimmapaya, Arunasalam Navaraj, Bayar Thimmapaya

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03325517 (Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03325517 unknown statusnot on this mapstarted 2017, after this paper: background citation

Effect of Adenovirus E1A Oncogene on DNA Replication Dynamics

TypeobservationalSponsorHeba Momen kamelRan2017 to 2019Enrolled50ConditionsAdenovirus
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Sudhakar BaluchamyDepartment of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Avenue, Chicago, IL 60611, USA.
Hasan N Rajabi
Rama Thimmapaya
Arunasalam Navaraj
Bayar Thimmapaya
Northwestern University · USCalifornia University of Pennsylvania · USHarvard University Press · US

Funding

FUNCTIONS OF AN EIA-ASSOCIATED CELLULAR PROTEINR01CA074403 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI THIMMAPAYA, BAYAR · 1998 to 2010
$2.8M
NCI NIH HHS CA74403NCI NIH HHS R01 CA074403
6 · The paper itself

Abstract

p300 and cAMP response element binding protein (CREB)-binding protein (CBP) are two highly homologous, conserved transcriptional coactivators, and histone acetyltransferases (HATs) that link chromatin remodeling with transcription. Cell transformation by viral oncogene products such as adenovirus E1A and SV40 large T antigen depends on their ability to inactivate p300 and CBP. To investigate the role of p300 in cell-cycle progression, we constructed stable rat cell lines, which conditionally overexpress p300 from a tetracycline-responsive promoter. When p300 was induced in these cells, serum-stimulated S-phase entry was significantly inhibited. The inhibition of S-phase induction was associated with down-regulation of c-Myc, but not of c-Fos or c-Jun. Simultaneous overexpression of c-Myc and p300 before serum stimulation reversed the inhibition of S-phase induction to a significant level, indicating that the inhibition of c-Myc to a large extent is responsible for the p300 inhibition of G1 exit. Similar studies with stable rat cell lines that overexpress a mutant p300, which lacks the HAT activity, showed that the intrinsic HAT activity of p300 is not required for the negative regulation of c-Myc or G1. These findings, and our previously published results (Kolli, S., Buchmann, A. M., Williams, J., Weitzman, S. & Thimmapaya, B. (2001) Proc. Natl. Acad. Sci. USA 98, 4646-4651), establish an important negative regulatory role for p300 in c-Myc expression that may be important in maintaining the cells in the G0/G1 phase of the cell cycle.

Indexed as

AcetyltransferasesAdenoviridaeAnimalsBlotting, NorthernCell CycleCell LineDNADown-RegulationE1A-Associated p300 ProteinG1 PhaseGenetic VectorsHistonesNuclear ProteinsPrecipitin TestsProto-Oncogene Proteins c-mycRatsAcetyltransferasesDNAE1A-Associated p300 ProteinEp300 protein, ratHistonesNuclear ProteinsProto-Oncogene Proteins c-mycTrans-Activators

Identifiers

PMID12883011
PMCPMC170951
OpenAlexW2016859030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.